Aarti Pharmalabs (AARTIPHARM) Share Price Rises 5.51% to Rs 964.40
- September 29, 2026
- Posted by: Kunal Singla
- Category: News
Aarti Pharmalabs Share Price is trading at Rs 964.40, up 5.51% today, with market capitalisation at Rs 8,514.38 Cr. The move places Aarti Pharmalabs Share Price among the notable healthcare gainers in today’s market update, but according to Univest data, the price event is confirmed, while no company-specific catalyst is established. For readers tracking Aarti Pharmalabs Share Price Today, the key point is that the stock moved higher from the previous close of Rs 914 and is trading near the day’s high. In this Aarti Pharmalabs Stock News update, the first question is what changed in price action, followed by what the valuation and sector context suggest. Investors following Aarti Pharmalabs Share Price Live can also watch whether the move aligns with broader healthcare stock performance on the NSE and BSE.
Aarti Pharmalabs Share Price today is relevant because the stock is rising today without a verified event trigger in the visible data. That makes the move more about measurable price action than a fresh business announcement. Univest data helps frame the Aarti Pharmalabs Share Price rise alongside fundamentals, sector benchmarks and peer comparison, so the day’s move can be read in context rather than in isolation.
Aarti Pharmalabs Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 964.4 |
| Previous Close | Rs 914 |
| Today's Move | Rs 50.4 (+5.51%) |
| Open | Rs 912 |
| High | Rs 964.4 |
| Low | Rs 908.85 |
| Market Capitalisation | Rs 8,514.38 crore |
| Market Cap Category | Mid Cap |
Aarti Pharmalabs Ltd. (AARTIPHARM) rose to Rs 964.4 from the previous close of Rs 914, a move of Rs 50.4 or 5.51%. The stock opened at Rs 912, reached a high of Rs 964.4, recorded a low of Rs 908.85.
Aarti Pharmalabs Share Price Today shows a clear intraday rise: the stock opened below the previous close, moved through the day, and last traded at Rs 964.40 after touching the day’s high of Rs 964.40. The day’s low stood at Rs 908.85, while the previous close was Rs 914.
The Aarti Pharmalabs Share Price update shows a day change of Rs 50.40, or 5.51%, from the previous close. The open was Rs 912, which places the current quote meaningfully above the opening level and above the previous session reference. For readers comparing Aarti Pharmalabs Share Price with recent stock performance, the movement is straightforward: the stock has gained today and is trading at the top of the day’s range. In Aarti Pharmalabs Stock News terms, the move is price-action driven, and according to latest Univest figures, the rise is confirmed even though no company-specific catalyst is established. That keeps attention on Aarti Pharmalabs Share Price Today rather than on any unverified explanation, and it leads naturally into the company’s fundamental analysis.
Aarti Pharmalabs Ltd. (AARTIPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 8,514.38 crore |
| P/E Ratio | 38.88x |
| P/B Ratio | 3.78x |
| ROE | 8.5% |
| ROCE | 10.77% |
| EPS | Rs 23.51 |
| Book Value Per Share | Rs 241.54 |
| Dividend Yield | 0.38% |
Aarti Pharmalabs Ltd. (AARTIPHARM) fundamental metrics show P/E 38.88x, P/B 3.78x, ROE 8.5%, ROCE 10.77%. Taken on their own, these numbers offer context rather than a trading signal.
Aarti Pharmalabs Ltd. has a market capitalisation of Rs 8,514.38 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 38.88x, P/B at 3.78x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.5% and ROCE of 10.77%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 23.51, book value per share of Rs 241.54, dividend yield of 0.38%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.59x, median ROE of 11.7%, median ROCE of 13.61%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 38.88x |
| Benchmark Median P/E | 32.59x |
| Benchmark Average P/E | 49x |
| Benchmark P/E Range | 3.46x to 707.31x |
| Company P/B Ratio | 3.78x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 8.5% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 10.77% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 8,514.38 crore |
| Benchmark Median Market Cap | Rs 783.26 crore |
Aarti Pharmalabs Ltd. (AARTIPHARM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Aarti Pharmalabs Ltd. (AARTIPHARM) has a P/E ratio of 38.88x, which is above the benchmark median of 32.59x, a difference of +19.3%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROE of 8.5%, which is below the benchmark median of 11.7%, a difference of -27.35%. Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROCE of 10.77%, which is below the benchmark median of 13.61%, a difference of -20.87%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 36.5 | 5.1 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,55,115.31 | 86.51 | 14.33 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,613.38 | 84.92 | 20.64 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,19,899.96 | 26.79 | 4.48 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,12,875.68 | 33.29 | 3.19 | 11.83 | 16 |
Aarti Pharmalabs Ltd. (AARTIPHARM) has a P/E ratio of 38.88x compared with the displayed peer median of 36.5x. The comparison is relative and should not be read as a recommendation. Its ROE of 8.5% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 10.77% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Aarti Pharmalabs Ltd. (AARTIPHARM) has a market capitalisation of Rs 8,514.38 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Aarti Pharmalabs
- Aarti Pharmalabs Share Price is up 5.51% today and is trading at the day’s high, which makes it a key mover in current market updates.
- The company’s market capitalisation of Rs 8,514.38 Cr keeps Aarti Pharmalabs Share Price firmly relevant in Healthcare stock news.
- Aarti Pharmalabs Fundamental Analysis shows P/E, P/B, EPS, book value and dividend yield that investors can compare with the sector benchmark.
- The company’s ROE of 8.5% and ROCE of 10.77% sit below the industry medians, which adds context to Aarti Pharmalabs Share Price Today.
- Peer comparison places Aarti Pharmalabs Share Price between lower and higher valuation names in Pharmaceuticals & Drugs, making it useful for stock performance tracking.
About Aarti Pharmalabs
Aarti Pharmalabs Share Price belongs to Aarti Pharmalabs Ltd., a company in the Healthcare sector and the Pharmaceuticals & Drugs industry. The business profile in Univest’s stock context places the company among listed pharmaceutical names that investors monitor for price action, financial ratios and sector comparison. For Aarti Pharmalabs Share Price Today, the focus is on how the company is positioned within its industry rather than on broad claims.
Aarti Pharmalabs Share Price is relevant because the company operates in a sector where valuation and return ratios vary widely across peers. The market capitalisation of Rs 8,514.38 Cr indicates a meaningful listed presence, while the reported P/E, P/B, ROE, ROCE, EPS, book value and dividend yield help frame Aarti Pharmalabs Stock Performance. Readers tracking Aarti Pharmalabs Company News can use these figures to place the stock’s day move in a wider business and valuation context.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Aarti Pharmalabs Share Price rising today?
Ans. Aarti Pharmalabs Share Price is rising today because it has gained 5.51% to Rs 964.40. Univest figures confirm the price action, but they do not point to a specific company trigger.
What is Aarti Pharmalabs Share Price Today?
Ans. Aarti Pharmalabs Share Price Today is Rs 964.40, up Rs 50.40 from the previous close of Rs 914. The stock is trading near the day’s high, which stood at Rs 964.40.
What is Aarti Pharmalabs market capitalisation?
Ans. Aarti Pharmalabs Market Cap stands at Rs 8,514.38 Cr. That places the company above the industry median market capitalisation in the same industry benchmark set, while still below the industry average.
How does Aarti Pharmalabs Share Price compare with sector valuation?
Ans. Aarti Pharmalabs Share Price is valued at 38.88 times earnings, above the industry median P/E of 32.59 and below the industry average of 49. Its P/B of 3.78 is also above the median.
What does Aarti Pharmalabs fundamental analysis show?
Ans. Aarti Pharmalabs Fundamental Analysis shows EPS of Rs 23.51, book value of Rs 241.54, dividend yield of 0.38%, ROE of 8.5% and ROCE of 10.77%. These figures help explain valuation context.
How is Aarti Pharmalabs performing versus peers?
Ans. Aarti Pharmalabs Share Price has a lower market cap than large peers such as Sun Pharmaceutical, Divi's Laboratories and Torrent Pharmaceuticals. Its ROE and ROCE are also below several listed peer companies.
Which sector and industry does Aarti Pharmalabs belong to?
Ans. Aarti Pharmalabs belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That placement is useful for Aarti Pharmalabs Share Price analysis because valuation and return ratios can then be compared with the correct benchmark set.
Should investors track Aarti Pharmalabs Share Price on Univest?
Ans. Investors tracking Aarti Pharmalabs Share Price can use Univest to follow live price movement, market cap, valuation ratios and peer context. That makes Aarti Pharmalabs Stock News easier to read alongside sector benchmarks.
Track Aarti Pharmalabs Share Price on Univest
Use Aarti Pharmalabs Ltd. (AARTIPHARM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Aarti Pharmalabs Share Price can be tracked on Univest for live price movement, valuation ratios, 52-week levels and market insights. For readers following Aarti Pharmalabs Share Price Today, Univest brings together price action, fundamentals, sector context and peer comparison in one place.
If you are monitoring Aarti Pharmalabs Stock News, the most practical use is to follow the share price update, market cap, P/E, P/B, ROE, ROCE and earnings-linked metrics as they change. That makes Aarti Pharmalabs Share Price useful for regular stock analysis without turning it into a recommendation.
